Medical science is making progress in detecting Alzheimer's disease through blood-based testing, raising an important question about whether healthcare policy can keep pace with the technologies being developed. Earlier detection can give patients and families valuable time to understand a diagnosis, explore appropriate treatment options and make decisions about their future. However, the availability of new diagnostic technology doesn't automatically mean patients can access it or that their insurance will cover it. The Alzheimer's Screening and Prevention Act seeks to establish a Medicare coverage pathway for certain FDA-approved blood-based screening tests. Patients Rising is following this legislation because delays in accessing medical advances have consequences for patients and families already navigating the uncertainty of a progressive disease.

Medical device maker Boston Scientific has sued Johnson & Johnson subsidiary Atraverse Medical in Delaware federal court, alleging Atraverse's Hotwire heart-procedure device infringes one of its patents.

medical ai keeps advancing, now you can take the bones out of a chest X-ray 🩻 @qure_ai released a model that splits a radiograph into soft tissue, bone and lungs, so the ribs stop hiding what's behind them ▶️ on Spaces